早发性痴呆患者诊断前15年的长期收入与生产力损失
该回顾性人群队列研究纳入793例早发性痴呆(EOD)患者及7926名匹配对照,利用全国税务记录评估诊断前15年的收入轨迹与生产力损失。结果显示EOD患者诊断前15年即出现显著且逐渐增加的生产力损失,人均累计损失74577欧元,且不同亚型损失轨迹存在差异。
要点
- EOD患者诊断前15年即出现生产力损失,人均累计损失74577欧元。
- 阿尔茨海默病组诊断前6年出现损失,诊断时达11431欧元。
- 额颞叶痴呆组诊断前11年出现损失,诊断时达16116欧元。
核心结论
- EOD患者在诊断前15年即出现显著生产力损失,且不同痴呆亚型的损失轨迹存在差异。
研究设计与样本
- 回顾性、人群为基础的纵向队列研究,纳入2010年1月至2021年12月Kuopio大学医院和Oulu大学医院转诊区域的所有EOD患者793例,并为每例患者随机匹配10名对照,共7926名对照。
主要发现
- EOD患者相比匹配对照,诊断前15年内生产力损失显著且逐渐增加,人均累计损失74577欧元(95%CI 46423-102732)。
- 阿尔茨海默病组诊断前6年出现生产力损失(2767欧元;95%CI 18-5515;p=0.024),诊断时达11431欧元(95%CI 8676-14184;p<0.001)。
- 额颞叶痴呆组诊断前11年出现损失(4799欧元;95%CI 433-9166;p=0.031),诊断时达16116欧元(95%CI 11671-20561;p<0.001)。
- α-突触核蛋白病组差异可变,仅诊断时显著(11284欧元;95%CI 2574-19993;p<0.011)。
- 其他EOD组(主要为血管性和混合性痴呆)生产力损失在整个随访期间持续较高,诊断时为8744欧元(p<0.001)。
临床怎么用
- 临床医生应认识到EOD患者在诊断前多年即存在生产力损失,早期识别和针对性干预可能有助于减轻社会经济负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Early-onset dementia (EOD), affecting individuals younger than 65 years, imposes a substantial socioeconomic burden. However, evidence on long-term income trajectories and productivity loss across EOD subtypes remains limited. The aim of this study was to evaluate income trajectories and societal productivity loss in individuals with different EOD subtypes. METHODS: This retrospective, population-based longitudinal cohort study included all patients with EOD from Kuopio University Hospital and Oulu University Hospital referral area between January 2010 and December 2021. Diagnoses were re-validated through clinical data review. For each study case, 10 randomly selected matched controls were used. Demographics, education, and comorbidities were obtained from national registers. Annual gross income was retrieved from Statistics Finland tax records. The Human Capital Approach was used to calculate productivity losses, in effect by estimating the annual income difference relative to controls using a generalized estimating equation regression model, with panel data spanning 15 years before diagnosis and the year of diagnosis. RESULTS: The EOD cohort comprised 793 patients (50.4% women; mean age 59.6 years): 421 with Alzheimer disease (AD), 179 with frontotemporal dementia (FTD) spectrum disorders, 46 with α-synucleinopathies (α-SYNUs), and 147 with other EOD etiologies. Compared with 7,926 age-matched and sex-matched controls, patients with EOD showed substantial and progressively increasing productivity loss up to 15 years before diagnosis, with cumulative losses of €74,577 (46,423-102,732) per patient. In the AD group, productivity loss emerged 6 years before diagnosis (€2,767; 95% CI 18-5,515; p = 0.024) and reached €11,431 at diagnosis (95% CI 8,676-14,184; p < 0.001). In the FTD group, loss appeared 11 years before diagnosis (€4,799; 95% CI 433-9,166; p = 0.031) and increased to €16,116 at diagnosis (95% CI 11,671-20,561; p < 0.001). In the α-SYNU group, differences were variable and significant only at diagnosis (€11,284; 95% CI 2,574-19,993; p < 0.011). In the "other EOD" group (predominantly vascular and mixed dementias), productivity loss remained consistently high across the follow-up (e.g., €8,744 at diagnosis; p < 0.001). DISCUSSION: This large-scale longitudinal study demonstrates significant productivity loss up to 15 years before EOD diagnosis, with variation across dementia subtypes. Earlier recognition and targeted interventions are needed in the future to mitigate the substantial socioeconomic burden of EOD. TRIAL REGISTRATION INFORMATION: This study is part of DEGE-RWD-research project (protocol registered to ClinicalTrials.gov: NCT06209515), coordinated by Neurocenter Finland.
引用
- Kivisild A, Aaltonen M, Aho K, et al. Long-Term Income and Productivity Losses in Individuals With Early-Onset Dementia: Evidence From 15 Years Preceding the Diagnosis. Neurology. 2026. PMID: 42418748. doi:10.1212/WNL.0000000000218268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。